To determine the effects of the 7aaRGD peptide on tumor-infiltrating myeloid cells in vivo, we compared the transcriptomic profiles of FACS-sorted glioma-associated CD11b+ cells from all experimental groups. The gene discussed is ITGAM; the disease is neoplasm.